Healthcare >> CEO Interviews >> October 12, 2001
JEREMY LEVIN became CEO of Physiome Sciences in January 2000 and was
Chairman from the company's inception until February 2001. Dr. Levin was
formerly President, CEO and Chairman of Cadus Pharmaceutical Corporation
in Tarrytown, NY. He serves on the New York Biotechnology Association
and previously served on the Executive Committee and the Emerging
Companies Section of the Board of the Biotechnology Industry
Organization. Dr. Levin serves on the Boards of Orchid BioSciences, Inc
and ViaLactia, Ltd. Profile
Dr. Levin: Physiome is the only company that is attempting, and has
succeeded in modeling protein/protein interactions, protein
